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Bone-marrow derived mesenchymal stromal cells (BMSCs) have been
in clinical trials for therapy. One major bottleneck in the advance-
ment of BMSC-based products is the challenge associated with cell
isolation, characterization, and ensuring cell ﬁtness over the course of
in vitro cell propagation steps. The data in this report is part of
publications that explored the proteomic changes following in vitro
passaging of BMSCs [4] and the molecular heterogeneity in cultures
obtained from different human donors [5,6].The methodological
details involving cell manufacturing, proteome harvesting, protein
identiﬁcation and quantiﬁcation as well as the bioinformatic analyses
were described to ensure reproducibility of the results.
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Cell cult
Sampl
PCBM1
PCBM1
16769
110877
8F356Protein and peptide identiﬁcations and quantiﬁcation statistics followed by GO
term enrichment using differentially regulated proteinsow data was
acquiredThe MS data was acquired using data-independent acquisition mode (UPLC–MSE
(Synapt G2, Waters) and processed using PLGS, DAVID, PANTHER, Aray Track
ata format CSV raw ﬁles exported from PLGS software and tables
xperimental
factorsBone-marrow derived mesenchymal stromal cells (BMSCs) were cultured and
collected at three passage stages (P3, P5, and P7). Protein expression changes
were comparatively analyzed using label-free proteomic techniquexperimental
featuresTotal proteome was collected, proteins digested using trypsin, and known
internal standards were spiked for relative quantiﬁcation of proteins.ata source
locationUS Food and Drug Administration, USAata accessibility Data are included in this article, S1 and S1_ExpD
Value of the data
 BMSC cultures from ﬁve human donors (Table 1) were harvested at three different passages (P3, P5,
and P7).
 The proteomic changes with in vitro aging of BMSCs were explored using label-free protein
quantiﬁcation technology.
 Across three passages, over 7000 proteins were identiﬁed and with the help of statistical ﬁlters
differentially regulated proteins were identiﬁed.
 Extensive bioinformatic and GO enrichment analyses helped in describing the systematic changes
in BMSCs induced by in vitro aging. Further, the data provide comprehensive proteomic archi-
tecture of BMSCs and thus serve as a rich source to identify molecular ﬁngerprints of BMSCs.1. Experimental design
1.1. Protein extraction using pressure cycling technology (PCT)
HBMSCs were thawed and dispersed in 50 mM Tris-HCl (Quality Biological, Gaithersburg, MD)
containing 1% protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO), 20 mM dithiothreitol, DTT,
(Pierce, Rockford, IL), and 1.25% sodium dodecyl sulfate (SDS). The suspension was sonicated in an
ultrasonic cleaner (FS110D, Fisher Scientiﬁc, Pittsburgh, PA) for 60 min at 25 °C to ensure complete
suspension of cells. The sample was transferred into a 1.4 mL single-use FT100-ND PCT pulse tube and
placed in the Barocycler (NEP3229, Pressure Biosciences, South Easton, MA). Pressure in the tube was
alternated for 20 cycles according to the following plan: high pressure ( 35,000 psi) for 20 s followed
by ambient pressure for 10 s at room temperature. The temperature of the reaction chamber was
controlled via a circulating water bath. The lysate was transferred to a LoBind tube (Eppendorf), spun
at 16,100g for 10 min (model 5415D centrifuge, Eppendorf), and the supernatant was collected. The
total protein content was determined using 2-D Quant kit (GE Healthcare, Piscataway, NJ) accordingure sources and donor characteristics.
e ID Sex Age Source
632 M 24 All cells
662 F 31 All cells
6 F 22 Lonza
M 22 Lonza
0 F 24 Lonza
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Scientiﬁc, Rockford, IL) as described in the user's guide, and protein solution was stored at 80 °C for
further processing
1.2. GELFREE protein fractionation and digestion
The cell lysates from lines PCBM1632 and 167696 were fractionated into six using the gel-eluted
liquid fraction entrapment electrophoresis (GELFREE) protein fractionation system (Protein Discovery,
Knoxville, TN). Sufﬁcient volume of cell lysate corresponding to 200 μg total protein was mixed with
30 μL acetate sample buffer, DTT to 50 mM ﬁnal concentration, and the volume was adjusted to
150 μL using MS-grade water. The mixture was heated for 10 min at 50 °C and loaded onto an 8% tris-
acetate cartridge (Protein Discovery, Knoxville, TN). Fractionation was carried out using the GELFREE
8100 protein fractionation system (Protein Discovery, Knoxville, TN). Prior to sample loading, HEPES
buffer (Protein Discovery, Knoxville, TN) was ﬁlled into the anode and cathode reservoirs as well as
the receiving chambers. Six fractions (F1–F6) were collected at 57.5, 61.5, 64.5, 68.5, 76.5, and
138.5 min from the time of loading using 50 eV for the ﬁrst two fractions and 100 eV for the rest. Each
time a fraction was collected; a fresh 150 μL HEPES buffer was introduced to collect the next round of
fraction. From triplicate runs the respective fractions were combined and the volume was reduced to
approximately 125 μL using SpeedVac Concentrator (ThermoFisher Scientiﬁc, Asheville, NC). Samples
were then desalted using Pierce-detergent removal spin column (Thermo Scientiﬁc, Rockford, IL) and
RapiGest SF (Waters Corp., Milford, MA) was added to 0.1% ﬁnal concentration. Proteins were digested
overnight using sequencing grade porcine trypsin (Promega, Madison, WI) following a standard
procedure of reduction (10 mM DTT), alkylation (50 mM iodoacetamide), and quenching (10 mM
DTT) prior to trypsin addition. The digestion was stopped by adding triﬂuoroacetic acid (TFA) to pH
2 and the RapiGest SF was hydrolyzed (37 °C for 30 min) and separated by centrifugation at 10,000g
for 10 min. The digested samples were kept at 80 °C until further analysis. GELFREE fractionation
step was omitted for cell lines from 110877, 8F3560, and PCBM1632. For these, tryptic digests were
prepared directly from the whole cell lysates for reasons described in the paper.
1.3. MS data acquisition, processing, database searching, label-free quantiﬁcation, and bioinformatic
analyses
1.3.1. LC–ESI–MSE acquisition
2D RP/RP nanoLC separation of protein digests was performed using the nanoACQUITY UPLC
system (Waters Corp.). The system was equipped with two binary solvent managers (BSMs), an
autosampler, nano-tees, and switching valves. The ﬁrst dimension BSM (1D BSM) eluted peptides at
pH 10 from a fractionation column (XBridge C18, 300 μm, 5 mm, 3.5 μm, Waters Corp.), while the 2D
BSM took eluent from 1D BSM, reduced the pH to 2 and decreased the organic content of the mobile
phase through dilution to capture peptides on the trap column (Symmetry, C18, 300 μm, 5 mm, 5 μm,
Waters Corp.). Peptides were then eluted using 2D BSM on the analytical RP column (Atlantis, 10 kpsi
nanoAcquity, 75 μm, 100 mm, 1.7 μm, Waters Corp.).
For samples from cell lines 167696 and PCBM1632 (fractionated using GELFREE system as
described in Section 1.2); 25 μL digest was aliquoted and volume-reduced to 10 μL using SpeedVac
Concentrator, from which 2 μL (a full loop) was loaded onto the 1D RP column. A discontinuous
gradient consisting of solvent A1 (20 mM ammonium formate, prepared from 28% NH4OH and FA
solutions) and solvent B (0.1% formic acid (FA) in ACN) were used to elute peptides in six fractions
(F1–F6) at 2 μL/min. Fractionation was done by eluting for 5 min according to the following gradient:
F1 eluted at 11.1% B; F2 at 14.5%, F3 at 17.4%, F4 at 20.8%, F5 at 45.0%, and F6 at 65.0% B. The sub-
sequent 2D separation involved a 60 min run at 0.3 μL/min using Solvent A2 (0.1% FA in H2O) and B. A
linear gradient of 1–65% B in 30 min followed by an increase to 85% B in 1 min then decreased to 1% B
in 5 min was used. A 24 min re-equilibration was introduced before the next fraction was eluted.
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fractionation and trap columns remained at room temperature. The samples from cell lines 110877,
8F3560, and PCBM1662 were analyzed without prior GELFREE protein fractionation steps. Instead of
protein fractionation, which signiﬁcantly adds to the overall analysis time, the tryptic digest prepared
from the total cell lysate was fractionated directly on the ﬁrst RP column into 13 fractions prior to the
second dimension separation on the analytical column. In this case a total of 7.5 mg digested sample
was loaded on the the ﬁrst RP column. The fractionation follows the following program: F1 eluted at
6% B; F2 at 7.5%, F3 at 9%, F4 at 11%, F5 at 12.6%, F6 at 14% B, F7 at 15.3%, F8 at 16.7% B; F9 at 18.3%, F10
at 20.4%, F11 at 23.5%, F12 at 50%, and F13 at 70% B. The subsequent 2D separation was performed as
described for cell lines 2 and 3.
An online MS analysis was carried out using either SYNAPT-G2 (Waters Corp.). Acquisition using
these instruments does not require the ion transmission window to be set during precursor ion scan
prior to collision dissociation experiments. Rather, it alternates the collision energy between high and
low levels (MSE) on a scan-by-scan basis to acquire all data points and achieves the maximum pos-
sible duty cycle [1]. The latter acquisition mode improves the sensitivity with subsequent improve-
ment in the overall proteomic coverage because data are collected on all isotopes of every charge state
across the entire chromatographic peak. The NanoAcquity UPLC and q-TOF MS were coupled through
a nanoESI emitter (7 cm, 10 μm tip opening, New Objective). Both the UPLC and MS systems were
controlled by Masslynx software, v.4.1 (Waters Corp.). A continuum positive ion was acquired via
data-independent acquisition mode (DIA, MSE). During MSE data acquisition, the quadrupole was set
to transfer all ions between m/z 300 and 2000, while the collision cell alternate between low (4 eV)
and high collision energies (15–45 eV) to record the abundances of precursor and fragment ions,
respectively. To maintain the mass accuracy throughout the analyses, 2 ng/μL leucine enkephaline
(Waters Corp.) was infused using a lock-spray apparatus and scanning was performed intermittently
every 60 s for 3 s. Mass error corrections was performed post-acquisition during data processing. The
TOF analyzer was externally calibrated using 100 fmol (Glu1)-ﬁbrinopeptide (Waters Corp.) and all MS
experiments were performed in v-mode with typical resolution of at least 10000 FWHM.
1.3.2. Data processing and database searching
LC–MSE raw data were processed using the Proteinlynx Global Server v.2.4 (PLGS) (Waters Corp.)
[2]. The time alignment of MSE data resulted in series of precursor and product ion tables. The product
ion spectra were searched against Swiss-Prot human protein database using the PLGS. The search was
limited to 10 ppm for the precursor and 20 ppm for fragment ion mass tolerances. Trypsin was set for
the enzyme and up to 3 missed cleavages were allowed. Carbamidomethylation of cystein residues asFig. 1. Dynamic range of proteins identiﬁed from hBMSCs (cell line PCBM1632). The average intensity of total product ions
from triplicate runs was in log with base 10 plotted against protein accesion numbers.
Fig. 2. Performance evaluation of T3IP-based protein quantitation for hBMSC lysate. Catalase and ALDH (ratio 2.75:1) were
mixed into MSC cell lysate and injected. I3P ratio was calculated after 2D fractionation and MS analysis.
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considered. In addition, the following limitation were set to facilitate the protein identiﬁcation pro-
cess: at least 3 product ion per peptide and 7 ion matches per protein, 100 ion counts for low and 75
ion counts for high energy acquisitions, and 1000 counts intensity threshold. The LC–MSE data were
also queried with one-time randomized version of the Swiss-Prot human protein database for the FDR
calculation.
1.3.3. Label-free protein quantiﬁcation and bioinformatic analyses
Overall, over 700 proteins were conﬁdently identiﬁed (See S1, S1_Exp and also [5,6]) and as
estimated by the average of protein-matched peptide intensity sum in triplicate runs at P3 the
dynamic range of proteins expressed in hBMSCs spans 4–6 orders of magnitude (Fig. 1). The label-free
protein quantitation method adopted in this study takes advantage of the linear relationship between
MS signal response and protein concentration [8]. To assess the suitability of the protein quantiﬁ-
cation method for BMSC lysates, we spiked bovine catalase and alcohol dehydrogenase (ALDH) at the
molar ratio of 2.75:1 to the hBMSC digest. Multiple runs of 2D nanoLC–MSE were acquired. The MS
signal response ratios of catalase and ALDH over multiple injections in separate days was determined
to be stable with an overall 16% coefﬁcient of variation (Fig. 2). Furthermore, as applied to the actual
hBMSCs proteome, the run-to-run quantitative repeatability was fairly robust as demonstrated in
Fig. 3. Fig. 3A represents the run-to-run quantitative repeatability when digests were prepared with
protein fractionation step (PCBM1632 at P3) prior to nanoLC–MSE analyses, while Fig. 3B represents a
step without upfront protein fractionation (PCBM1662 at P5).
Subcellular location prediction for identiﬁed proteins was performed using PANTHER server [3]
and GProX was used for clustering analysis [7]. Biological function, protein network assignment, and
other bioinformatic analyses were performed using either the Ingenuity Pathway Analysis application
(IPA v9, Ingenuity Systems Inc, USA) or ArrayTrack data analysis and interpretation tool (www.fda.
gov/ScienceResearch/BioinformaticsTools/Arraytrack). In IPA, Core Analyses were run using the focus
protein sets (differentially expressed proteins) together with the corresponding fold changes using
the default set parameters. Networks and biological functions were algorithmically generated and
signiﬁcance of each network and enriched functions was assessed using Fisher's exact test. Further-
more, the activation z-score, which is a measure of regulation of biological functions, was calculated
based on experimentally observed functional changes that are compiled in the Ingenuity Knowledge
Database (IKDB).
Fig. 3. The run-to-run reproducibility of a label-free quantitation workﬂow. Protein abundance was determined using three
most intense tryptic peptide signals. Panel A is an example, where ofﬂine protein fractionation step prior to trypsinization was
used and B exempliﬁes a sample preparation workﬂow without prior protein fractionation.
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
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